Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Alignment Healthcare (ALHC) Income from Non-Controlling Interests (2022 - 2025)

Alignment Healthcare's Income from Non-Controlling Interests history spans 4 years, with the latest figure at -$14000.0 for Q2 2025.

  • For Q2 2025, Income from Non-Controlling Interests fell 300.0% year-over-year to -$14000.0; the TTM value through Dec 2025 reached -$254000.0, down 605.56%, while the annual FY2025 figure was -$254000.0, 605.56% down from the prior year.
  • Income from Non-Controlling Interests reached -$14000.0 in Q2 2025 per ALHC's latest filing, up from -$240000.0 in the prior quarter.
  • In the past five years, Income from Non-Controlling Interests ranged from a high of $27000.0 in Q4 2024 to a low of -$240000.0 in Q1 2025.
  • Average Income from Non-Controlling Interests over 4 years is -$48909.1, with a median of -$22000.0 recorded in 2023.
  • Peak YoY movement for Income from Non-Controlling Interests: surged 222.73% in 2024, then tumbled 344.44% in 2025.
  • A 4-year view of Income from Non-Controlling Interests shows it stood at -$92000.0 in 2022, then soared by 76.09% to -$22000.0 in 2023, then soared by 222.73% to $27000.0 in 2024, then plummeted by 151.85% to -$14000.0 in 2025.
  • Per Business Quant, the three most recent readings for ALHC's Income from Non-Controlling Interests are -$14000.0 (Q2 2025), -$240000.0 (Q1 2025), and $27000.0 (Q4 2024).